Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004381644> ?p ?o ?g. }
- W2004381644 endingPage "936" @default.
- W2004381644 startingPage "929" @default.
- W2004381644 abstract "The balance of intracellular cholesterol has proven to be critical to the production of beta-amyloid (A beta). Reducing cholesterol in vitro leads to decreased production of A beta, whereas an increase in cellular cholesterol induces A beta production. Liver X Receptor (LXR) agonists are known to increase cholesterol efflux from cells, but there are conflicting reports as to the effects of these agonists on A beta production. We therefore examined the effects of efflux-inducing agents on A beta production in vitro. We used methyl-beta-cyclodextrin and an LXR agonist (TO-901317) to induce cholesterol efflux and studied the resulting A beta production in a stable amyloid precursor protein (APP) -transfected cell line. When cholesterol efflux was induced with methyl-beta-cyclodextrin there was a >60% decrease in A beta(40) and A beta(42) production. However, while activation of LXR using TO-901317-induced cholesterol efflux in the presence of a cholesterol acceptor, no changes in A beta levels were recorded. When cells were incubated with TO-901317 above the concentration required for maximal cholesterol efflux, there was a 150% increase in A beta(42) levels. The absence of a cholesterol acceptor from the culture media (preventing cholesterol efflux) did not blunt this increase in A beta(42), suggesting that the effects of TO-901317 on A beta(42) are efflux independent. These results were confirmed in APP stably transfected human H4 cells, which revealed in addition to a 200% increase in A beta(42) levels, a concomitant 80% reduction in A beta(38). A cell-free gamma-secretase assay confirmed that TO-901317 can directly alter gamma-secretase activity. These data demonstrate that TO-901317 can directly modulate the site of cleavage of APP by gamma-secretase in vitro." @default.
- W2004381644 created "2016-06-24" @default.
- W2004381644 creator A5002259431 @default.
- W2004381644 creator A5041175158 @default.
- W2004381644 creator A5067548726 @default.
- W2004381644 creator A5072214010 @default.
- W2004381644 creator A5074411763 @default.
- W2004381644 creator A5082978510 @default.
- W2004381644 creator A5087752305 @default.
- W2004381644 date "2007-01-23" @default.
- W2004381644 modified "2023-10-01" @default.
- W2004381644 title "Cholesterol independent effect of LXR agonist TO‐901317 on gamma‐secretase" @default.
- W2004381644 cites W1534001036 @default.
- W2004381644 cites W1963627192 @default.
- W2004381644 cites W1970055334 @default.
- W2004381644 cites W1974761264 @default.
- W2004381644 cites W1975806945 @default.
- W2004381644 cites W1992653391 @default.
- W2004381644 cites W1996457468 @default.
- W2004381644 cites W2009111659 @default.
- W2004381644 cites W2018962529 @default.
- W2004381644 cites W2026453296 @default.
- W2004381644 cites W2026596383 @default.
- W2004381644 cites W2028195118 @default.
- W2004381644 cites W2046454316 @default.
- W2004381644 cites W2057838273 @default.
- W2004381644 cites W2059256286 @default.
- W2004381644 cites W2068477037 @default.
- W2004381644 cites W2073420511 @default.
- W2004381644 cites W2085909854 @default.
- W2004381644 cites W2091241078 @default.
- W2004381644 cites W2096012124 @default.
- W2004381644 cites W2113690827 @default.
- W2004381644 cites W2116784956 @default.
- W2004381644 cites W2128084592 @default.
- W2004381644 cites W2140503956 @default.
- W2004381644 cites W2163110760 @default.
- W2004381644 doi "https://doi.org/10.1111/j.1471-4159.2007.04467.x" @default.
- W2004381644 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17472585" @default.
- W2004381644 hasPublicationYear "2007" @default.
- W2004381644 type Work @default.
- W2004381644 sameAs 2004381644 @default.
- W2004381644 citedByCount "26" @default.
- W2004381644 countsByYear W20043816442012 @default.
- W2004381644 countsByYear W20043816442013 @default.
- W2004381644 countsByYear W20043816442014 @default.
- W2004381644 countsByYear W20043816442015 @default.
- W2004381644 countsByYear W20043816442017 @default.
- W2004381644 countsByYear W20043816442020 @default.
- W2004381644 countsByYear W20043816442022 @default.
- W2004381644 crossrefType "journal-article" @default.
- W2004381644 hasAuthorship W2004381644A5002259431 @default.
- W2004381644 hasAuthorship W2004381644A5041175158 @default.
- W2004381644 hasAuthorship W2004381644A5067548726 @default.
- W2004381644 hasAuthorship W2004381644A5072214010 @default.
- W2004381644 hasAuthorship W2004381644A5074411763 @default.
- W2004381644 hasAuthorship W2004381644A5082978510 @default.
- W2004381644 hasAuthorship W2004381644A5087752305 @default.
- W2004381644 hasBestOaLocation W20043816441 @default.
- W2004381644 hasConcept C104317684 @default.
- W2004381644 hasConcept C126322002 @default.
- W2004381644 hasConcept C134018914 @default.
- W2004381644 hasConcept C167400880 @default.
- W2004381644 hasConcept C170493617 @default.
- W2004381644 hasConcept C185592680 @default.
- W2004381644 hasConcept C199360897 @default.
- W2004381644 hasConcept C200082930 @default.
- W2004381644 hasConcept C2776174256 @default.
- W2004381644 hasConcept C2778163477 @default.
- W2004381644 hasConcept C2778938600 @default.
- W2004381644 hasConcept C2779433975 @default.
- W2004381644 hasConcept C2910962261 @default.
- W2004381644 hasConcept C41008148 @default.
- W2004381644 hasConcept C55493867 @default.
- W2004381644 hasConcept C63932345 @default.
- W2004381644 hasConcept C71924100 @default.
- W2004381644 hasConcept C86339819 @default.
- W2004381644 hasConcept C86803240 @default.
- W2004381644 hasConceptScore W2004381644C104317684 @default.
- W2004381644 hasConceptScore W2004381644C126322002 @default.
- W2004381644 hasConceptScore W2004381644C134018914 @default.
- W2004381644 hasConceptScore W2004381644C167400880 @default.
- W2004381644 hasConceptScore W2004381644C170493617 @default.
- W2004381644 hasConceptScore W2004381644C185592680 @default.
- W2004381644 hasConceptScore W2004381644C199360897 @default.
- W2004381644 hasConceptScore W2004381644C200082930 @default.
- W2004381644 hasConceptScore W2004381644C2776174256 @default.
- W2004381644 hasConceptScore W2004381644C2778163477 @default.
- W2004381644 hasConceptScore W2004381644C2778938600 @default.
- W2004381644 hasConceptScore W2004381644C2779433975 @default.
- W2004381644 hasConceptScore W2004381644C2910962261 @default.
- W2004381644 hasConceptScore W2004381644C41008148 @default.
- W2004381644 hasConceptScore W2004381644C55493867 @default.
- W2004381644 hasConceptScore W2004381644C63932345 @default.
- W2004381644 hasConceptScore W2004381644C71924100 @default.
- W2004381644 hasConceptScore W2004381644C86339819 @default.
- W2004381644 hasConceptScore W2004381644C86803240 @default.
- W2004381644 hasIssue "4" @default.